The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the First Myocardial Infarction Risk Reduction Program

Background: Noncompliance with cardiovascular therapy and prevention initiatives is well documented. Objectives: The purpose of the First Myocardial Infarction (MI) Risk Reduction Program, an open-label drug registry involving mainly primary-care patients at increased risk of a first MI, was to exam...

Ausführliche Beschreibung